We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+9.29%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$408B
AUM Growth
+$12.1B
Cap. Flow
-$13.2B
Cap. Flow %
-3.25%
Top 10 Hldgs %
15.3%
Holding
6,669
New
429
Increased
2,205
Reduced
2,588
Closed
721

Sector Composition

Rank Sector Weight
1 Technology 14.79%
2 Healthcare 9.32%
3 Financials 8.97%
4 Consumer Discretionary 7.33%
5 Industrials 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTNB icon
5576
Matinas BioPharma
MTNB
$1.75M
$17.6K ﹤0.01%
+704
New +$23.4K
DRTSW icon
5577
Alpha Tau Medical Warrant
DRTSW
$78.9M
$17.4K ﹤0.01%
69,409
ABPWW
5578
DELISTED
Abpro Holdings Warrant
ABPWW
$17.3K ﹤0.01%
266,600
ARMP icon
5579
Armata Pharmaceuticals
ARMP
$172M
$17.2K ﹤0.01%
+13,907
New +$36.2K
DOYU
5580
DouYu International Holdings
DOYU
$144M
$17.2K ﹤0.01%
+1,226
New +$14.3K
GRTX
5581
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$16.9K ﹤0.01%
11,363
-92
-0.8% -$149
SPRU icon
5582
Spruce Power Holding Corp
SPRU
$44.1M
$16.9K ﹤0.01%
2,296
+937
+69% +$6.65K
MTEM
5583
DELISTED
Molecular Templates, Inc.
MTEM
$16.8K ﹤0.01%
3,419
-1,785
-34% -$14.8K
LOCL icon
5584
Local Bounti
LOCL
$23.5M
$16.7K ﹤0.01%
+922
New +$28.8K
LCTX icon
5585
Lineage Cell Therapeutics
LCTX
$284M
$16.5K ﹤0.01%
14,079
-1,394
-9% -$1.76K
SZZLW
5586
DELISTED
Sizzle Acquisition Corp. Warrant
SZZLW
$16.1K ﹤0.01%
53,822
OPAD icon
5587
Offerpad Solutions
OPAD
$22.1M
$15.3K ﹤0.01%
222
-408
-65% -$47.1K
ZPTAW
5588
DELISTED
Zapata Computing Holdings Inc. Warrant
ZPTAW
$15.2K ﹤0.01%
216,469
-100,301
-32% -$6.9K
SDC
5589
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$15.1K ﹤0.01%
+42,789
New +$28.2K
DNTH icon
5590
Dianthus Therapeutics
DNTH
$6.14B
$15K ﹤0.01%
2,379
-4,606
-66% -$81.5K
AQMS icon
5591
Aqua Metals
AQMS
$9.53M
$14.9K ﹤0.01%
60
ARVL
5592
DELISTED
Arrival Ordinary Shares
ARVL
$14.6K ﹤0.01%
1,831
-98
-5% -$2.33K
SEEL
5593
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$14.3K ﹤0.01%
5
-1
-17% -$3.49K
INFI
5594
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$14.1K ﹤0.01%
25,367
-49,375
-66% -$42K
SQZ
5595
DELISTED
SQZ Biotechnologies Company
SQZ
$13.5K ﹤0.01%
18,200
-7,595
-29% -$16.6K
DMS.WS
5596
DELISTED
Digital Media Solutions, Inc. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
DMS.WS
$13.2K ﹤0.01%
125,000
SOAR.WS
5597
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$12.9K ﹤0.01%
431,162
INZY
5598
DELISTED
Inozyme Pharma
INZY
$12.5K ﹤0.01%
+11,924
New +$20.8K
WEJO
5599
DELISTED
Wejo Group Limited Common Shares
WEJO
$12.5K ﹤0.01%
+25,898
New +$23.2K
ALTIW
5600
DELISTED
AlTi Global Inc Warrant
ALTIW
$12.4K ﹤0.01%
24,296

Similar funds

Goldman Sachs's Q4 2022 Portfolio in Review

As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.

  • Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
  • Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
  • Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
  • Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
  • Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
  • Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
  • Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.